Intensive Cardiac Care Unit, Świętokrzyskie Cardiology Center, 25-736 Kielce, Poland.
Biomed Res Int. 2013;2013:957027. doi: 10.1155/2013/957027. Epub 2013 Jun 6.
Coronary artery disease complicates only 0.01% of all pregnancies. For this reason, more exhaustive data on the management of such cases is lacking. Even guidelines on management of cardiovascular disease in pregnant women are scarce focusing mainly on acute myocardial infarction. This is a complex issue involving thorough evaluation of cardiovascular status in each pregnant woman, assessment of risk for developing coronary complications, and close cooperation with obstetric teams. Safety data on typical cardiac drugs such as statins, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or novel antiplatelet drugs are also scarce and their effect on the developing human fetus is not well understood. We present a review on the management of such patients.
冠心病仅占所有妊娠的 0.01%。因此,缺乏此类病例管理的更详尽数据。即使是关于孕妇心血管疾病管理的指南也很少,主要集中在急性心肌梗死上。这是一个复杂的问题,涉及到对每个孕妇心血管状况的全面评估、对发生冠状动脉并发症风险的评估,以及与产科团队的密切合作。他汀类药物、血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂或新型抗血小板药物等典型心脏药物的安全性数据也很少,其对发育中人类胎儿的影响也不明确。我们对这类患者的处理进行了综述。